Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

15.30
Delayed Data
As of Aug 21
 0.00 / 0.00%
Today’s Change
10.66
Today|||52-Week Range
19.90
+1.66%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues29.1M34.2M26.6M23.6M
 
 
 
 
 
Depreciation And Amortization2.3M2.2M1.6M2.1M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses45.1M42.4M57.7M59.6M
 
 
 
 
 
Research And Development31.6M26.4M36.1M39.1M
 
 
 
 
 
Total Operating Expenses47.3M44.5M59.2M61.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-18.2M-10.4M-32.6M-38.1M
 
 
 
 
 
Extraordinary Credit0.0051.2M0.000.00
 
 
Other Expenses38.0K65.0K833.0K57.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-17.5M41.5M-31.8M-36.9M
 
 
 
 
 
Net Income-17.5M41.5M-31.8M-36.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS68.8M69.0M69.7M73.4M
 
 
 
 
 
Shares To Calculate EPS Diluted68.8M69.4M69.7M73.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.26$0.60-$0.46-$0.50
 
 
 
 
 
EPS Diluted-$0.26$0.60-$0.46-$0.50